Nutritional Status Assessment of Pediatric Cystic Fibrosis Patients and Effect of Nutrition Education on Nutritional Status

Sponsor
Medipol University (Other)
Overall Status
Completed
CT.gov ID
NCT06109675
Collaborator
(none)
46
1
2
23
2

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to to assess the nutritional status of children diagnosed with cystic fibrosis between the ages of 2-14, to determine the changes in the nutrition education given to the mothers of the patients on the nutritional status of the children and the nutritional knowledge of the mothers, and to compare them with the control group.. The main questions it aims to answer are:

  1. Will be better the nutritional status of children of mothers in the education group will be better compared to the control group?

  2. Will the macro and micronutrient Recommended Dietary Allowance (RDA) and diet quality of children with cystic fibrosis in education group increase after nutrition education?

  3. Will the nutrition knowledge test scores of mothers of children with cystic fibrosis in education group on "Nutrition in Cystic Fibrosis" increase after nutrition education?

Mothers of children diagnosed with cystic fibrosis will participate in the study as a result of the call of the Cystic Fibrosis Association in Turkey. Mothers participating in the study will be divided into 2 groups. While the mothers in the first group will be given nutrition education 3 times a week, 1 hour a day, no education session will be given to the mothers in the control group. The nutritional status and nutrient consumption of children in the training group and the control group will be compared.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nutrition Education
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Nutritional Status Assessment of Pediatric Cystic Fibrosis Patients and Effect of Nutrition Education on Nutritional Status
Actual Study Start Date :
Sep 2, 2021
Actual Primary Completion Date :
Sep 2, 2022
Actual Study Completion Date :
Aug 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Education group

Behavioral: Nutrition Education
All mothers in this group will be given 3 nutrition education sessions including detailed informations on Nutrition Therapy in Cystic Fibrosis. In addition to the education sessions, an informational booklet and a high-energy sample recipe booklet will be given.

No Intervention: Control group

Outcome Measures

Primary Outcome Measures

  1. Malnutrition rate in children with cystic fibrosis [Beginning of the study, 1st and 3rd months of the study]

    According to the World Health Organisations (WHO) standarts; children who are more than 2 SD below the reference median are considered to be malnourished to be stunted, wasted or to be underweight. Children with measurements below 3 SD (a Z-Score of less than-3) are considered to be severely malnourished.

  2. Malnutrition rate in children with cystic fibrosis [Beginning of the study, 1st and 3rd months of the study]

    All children will also be evaluated according to the percentile recommendations in the guide of the European Cystic Fibrosis Society (ECFS). According to the ECFS guideline, those with height for age and BMI for age below the 50th percentile are classified as undernourished.

Secondary Outcome Measures

  1. The rate at which macronutrient and micronutrient consumption of children participating in the study meets the Recommended Dietary Allowance (RDA). [Beginning of the study, 1st and 3rd months of the study]

    Recommended Dietary Allowance (RDA): Average daily level of intake sufficient to meet the nutrient requirements of nearly all (97-98%) healthy individuals; often used to plan nutritionally adequate diets for individuals.The macro and micronutrient RDA is determined by the Food and Nutrition Board of the National Academies of Sciences Engineering, and Medicine.

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Mothers included in the research must have responded to the KIFDER (Cystic Fibrosis Association in Turkey) call.

  • Children of mothers included in the research must have been officially diagnosed with cystic fibrosis.

  • Mothers included in the research mustn't receive any nutrition education beforehand.

  • Children of mothers included in the research mustn't be regularly followed by a dietitian.

Exclusion Criteria:
  • Children of mothers included in the research mustn't have a feeding tube.

  • Children of mothers included in the research mustn't be diagnosed with any other disease known to affect growth.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul Medipol Unıversity Istanbul Turkey

Sponsors and Collaborators

  • Medipol University

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Merve Pehlivan, Phd(c), Medipol University
ClinicalTrials.gov Identifier:
NCT06109675
Other Study ID Numbers:
  • CyfNutEdu
First Posted:
Oct 31, 2023
Last Update Posted:
Oct 31, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Merve Pehlivan, Phd(c), Medipol University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 31, 2023